1 INTRODUCTION

Congenital Syphilis is caused by organism Treponema pallidum which is transmitted in newborns vertically from their mothers or through maternal lesion at the time of delivery. Untreated syphilis during pregnancy has a transmission rate close to 100% and causes fetal or perinatal death in 40% of affected infants.¹ Recent estimates indicate that congenital syphilis is the second leading cause of preventable stillbirths worldwide.² This condition can have numerous and complex symptoms that resemble other diseases. With the presentation often mimicking other conditions like skin rash, hemolytic anemia, paralysis of limbs, neurological manifestations.² After the advent of penicillin treatment in the 1940s, the incidence of syphilis had shown dramatic decrease. However, according to recent WHO report, the incidence of congenital syphilis is rapidly increasing all over the world with 700,000–1.5 million cases reported annually between 2016 and 2023.³ However due to widespread antenatal screening programs and penicillin treatment of mothers, the cases of congenital syphilis in rarely suspected and confirmed these days.

We report a case of congenital syphilis in hospital delivered newborn with adequate maternal antenatal checkup and presented with unusual hematological presentation along with skin lesion.

2 CASE PRESENTATION

2.2 Method (Differential diagnosis, investigation, and treatment)

When baby arrived to our center, he had ichthyic skin on the lower limbs with swelling of limb (Figure 1) and palpable liver 2 cm below the coastal margin. Blood tests showed anemia (Hb:8.3). The total leucocyte count was 40,000/mm³ with neutrophilic predominance, and Thrombocytopenia (Platelets: 70,000) was also present. His corrected reticulocyte count was 8% with a positive direct Coombs test (DCT). Peripheral blood smear showed anisocytosis, normocytic normochromic RBC with hypochromic red cells. Liver enzymes were also elevated.

As baby was preterm, low birth weight and was failing to thrive with hemolytic anemia, thrombocytopenia, TORCH infection was suspected. TORCH ELISA and RPR (Rapid Plasma Reagin) screen were sent, revealing a reactive RPR titre (1:64). Due to unavailability of crystalline penicillin, treatment with ceftriaxone was started.

CSF analysis was normal and CSF VDRL was negative. (Table 1) An x-ray of bilateral lower limbs revealed diffuse peri osteitis involving bilateral femur, tarsals, and metatarsals with destruction in evaluations were normal (Figure 2) The parents were treated accordingly with benzathine penicillin. After 2 weeks of treatment, the infant showed symptomatic improvement along with normal counts. (Table 2).

TABLE 1. Showing TORCH screening and VDRL titre.

Test	Value
RPR	Reactive (1:64)	Carbon particle flocculation
TORCH IgM ELISA
Toxoplasma gondii	Negative
Rubella virus	Negative
Cytomegalo virus	Negative
Herpes simplex virus I	Negative
Herpes simplex virus II	Negative
TORCH IgG ELISA
Toxoplasma gondii	Negative
Rubella virus	Negative
Cytomegalo virus	Negative
Herpes simplex virus I	Negative
Herpes simplex virus II	Negative

TABLE 2. Showing blood investigations.

Test	Value	Ref range
TLC	16,000	4000–11,000/cmm
Neutrophil	65
Lymphocyte	29
Monoctye	05
Eosinophil	01
Basophila	00
Hemogolobulin	8.3a	12–18 g/dL
PCV	24.8a	36–54
RBC	2.48a	4.5–5.5 million/cc
Platelets	70,000a
MCV	100	82–92 fl
MCHC	33.47	27–42%
MCH	33.47	27–32 pg
AST	149	0–5
ALT	57	0–50
Alkaline phosphatase	139	30–120

• Note: Bold values indicates high levels.
• ^a Indicates lower level.

3 DISCUSSION

Recognition of congenital syphilis is often challenging as clinical features are non-specific and variable. Most infants are asymptomatic at birth and may present only after several weeks to months of life.⁴ Negative VDRL report of mother during antenatal screening might be deceptive many a times. In our case also, the mother had been screened negative for serological evaluation of HIV, Hepatitis and RPR test during her first Antenatal Care (ANC) visit. Hence, we could not consider syphilis in our list of differentials during the initial assessment of the patient. Similar case reports of near miss of diagnosis due to first trimester screening being negative has been reported.⁵ With our case it has been further highlighted that physician need to be aware that syphilis can also be acquired at a later stage after antenatal screening. In areas of high incidence, a three-time points testing has been recommended: at the first visit, in the third trimester and at delivery by Center for Disease Control and Prevention (CDC). CDC recommendation also includes testing for syphilis in all women with fetal death after 20 weeks of gestation.⁶

Syphilis often has variable consequences during pregnancy and in the post-natal period affecting different systems of the body. Untreated syphilis during pregnancy has a transmission rate close to 100% and causes fetal or perinatal death in 40% of affected infants³ While there were few classical points in favor of congenital syphilis in our case, some of the presentations were contrary to the usual clinical picture. The points contrary to the usual findings were, the DCT being positive in our case. The usual findings are that of DCT negative hemolytic anemia. The positive DCT was more suggestive of autoimmune causes of hemolytic anemia and hepatomegaly. While autoimmune hemolytic anemia is rare after neonatal period, there has been reports of autoimmune hemolytic anemia in early days of life, with preceding infection.⁵ The patient presented to us during the coldest days of the year, making paroxysmal cold hemoglobinuria (PCH) another possibility. PCH is a complement mediated intravascular hemolysis, where antibody attaches to red cells at colder temperatures and causes red cell lysis when blood recirculates to warmer temperatures. The condition has also been associated with young children after a viral illness and congenital too.^{6, 7} However, the diagnosis of PCH could not be confirmed due to unavailability of Donath Landsteiner antibody test which is considered as pathognomic for the diagnosis.

While there have been reports of peeling of skin in association with congenital syphilis in few reports, the more common skin manifestation is that of maculopapular rash with small, initially red or pink spots⁸ These lesions found on the back, buttocks, posterior thighs, palms, and soles. These rashes usually persist for 2–3 weeks and then desquamate and forms crust. It fades to becomes copper color. Our patient present with desquamation without the initial maculopapular rash. While congenital syphilis was among our differentials, we did not conclude the case after the positive RPR report in the patient. Since the clinical scenario was also suggestive of autoimmune causes, with hemolytic anemia and deranged liver function, we speculated that the positive RPR could be false positive due to autoantibody as neonatal lupus.⁹ Only after positive results in the mother was the definite diagnosis of congenital syphilis made. The gold standard treatment of congenital syphilis is with penicillin. Ceftriaxone is an alternative especially in cases with allergy to penicillin.⁴ Due to unavailability of crystalline penicillin, we decided to start treatment with ceftriaxone to complete a 14-day course.

4 CONCLUSION

Syphilis involves most part of the body, with numerous and complex manifestations making diagnosis difficult. As has been reiterated with our case, syphilis is indeed “the Great Imitator.” Untimely diagnosis can have grave neurological and developmental consequences and thus congenital syphilis has to be one of the differentials in an infant with active infection and unidentified skin lesion.

AUTHOR CONTRIBUTIONS

Niharika Khanal: Writing – original draft. Jasmine Shakya: Supervision. Vivek Karn: Supervision. Srijana Basnet: Conceptualization. Daman Raj Paudel: Supervision. Sunita Tamang: Supervision.

FUNDING INFORMATION

No funding received.

CONFLICT OF INTEREST STATEMENT

Authors have no conflict of interest to declare.

ETHICS STATEMENT

Ethical approval does not imply to case reports from institutional IRB.

CONSENT

Written informed consent was obtained from the patient to publish this report in accordance with the journal's patient consent policy.